株式会社メディカルレビュー社

Name

株式会社メディカルレビュー社

Legal name

株式会社Medicinalレビュー社

Website

https://m-review.co.jp

Company type

Private

Founded year

1983

Operating status

Operating

Headcount range

11–50 employees

Short description

Medical Review Co., Ltd. is a Japanese healthcare communications company combining medical publishing (since 1983) with integrated B2B advertising agency services for 49 pharmaceutical manufacturer clients, structured around three divisions (Healthcare Communication, Promotion, Creative) and a new physician-facing AI assistant called JME.

Ownership category

akta.pro rank

Product category

Healthcare Communications & Pharmaceutical Advertising

NAICS

Advertising Agencies (541810)

akta.pro primary industry

Healthcare/Pharma Creative Agencies (MPAAAAAJ)

akta.pro secondary industries

Healthcare & Life Sciences PR (MPAAADAD), Medical & Clinical Reference (Physicians, Nursing, Allied Health) (EDAGAGAA)

Keywords

• Healthcare communications
• Pharmaceutical advertising
• Medical publishing
• Pharmaceutical marketing
• Medical copywriting services

Headquarters

HQ city

Tokyo

HQ country

Japan

HQ region

Asia

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Pharmaceutical Advertising & Promotion Services: Core revenue from providing integrated advertising and promotional services to pharmaceutical companies. Services include strategic planning, medical copywriting, digital production, and creative services for drug promotion materials, websites, and new drug launch campaigns.
2. Medical Publishing: Revenue from publishing medical books and journals, leveraging expertise accumulated since the company's founding in 1983 as a medical publisher.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Core offering

Medical Review Co., Ltd. provides integrated healthcare communications and advertising agency services to pharmaceutical companies, organized into three divisions — Healthcare Communication (account management and strategy), Promotion (medical copywriting and promotional material production), and Creative (digital direction, art direction, engineering, and data analytics). The company also operates a medical publishing business producing textbooks, reference materials, and journals for healthcare professionals, and has released the JME (Japan Medical Evidence) AI chat assistant for physicians in beta.

Product overview

Medical Review Co., Ltd. operates as a healthcare communications company combining medical publishing expertise with advertising agency services. The company is organized into three main divisions within its advertising agency business: Healthcare Communication Division (account management), Promotion Division (medical communications/promotional materials), and Creative Division (digital/media production). Core offerings include JME, an AI-powered medical chat service for physicians, and the ORGAN ROOMS PROJECT, a health awareness initiative. The publishing division creates medical content including the proprietary medical dictionary used by JME. Recent developments include the acquisition of Vivixy, an AI and web technology company, to strengthen AI capabilities across the group.

Differentiator

Problem solved

Functional benefit

Products and services

• Healthcare Communication Division (ヘルスケアコミュニケーション事業部) Account management and strategic planning service for pharmaceutical company clients. Manages project budgets and schedules, briefs and directs medical copywriters, creative and digital media teams, explores client insights, and develops strategic action plans for healthcare stakeholder communications.
• Promotion Division (プロモーション事業部) Medical communications unit that creates promotional materials for ethical pharmaceuticals across various media, including planning, production, and coordination with pharmaceutical companies for new drug launches and ongoing product promotion.
• Creative Division (クリエイティブ事業部) Creative services unit consisting of four groups: Digital Direction, Art Direction, Engineering, and Data Analytics. Provides digital planning, visual design, technical development, and PDCA cycle analysis for web and app products targeting healthcare professionals and patients.
• Medical Publishing (医学出版) Publishing business creating medical textbooks, reference materials, and educational content for healthcare professionals. The proprietary medical dictionary used by JME was developed from accumulated publication expertise.
• JME (Japan Medical Evidence) Free AI chat assistant service for physicians in Japan that provides evidence-based medical information by referencing PubMed papers and a proprietary medical dictionary (みんなの医学辞書) built from the company's published medical books. Provides cited, verifiable answers for clinical decision support.
• ORGAN ROOMS PROJECT Educational initiative promoting health awareness and disease prevention through art books, character merchandise (からだっぽん), and public events. A portion of merchandise sales is donated to pediatric healthcare facilities.

Quantifiable outcome

• Supported new drug launches and ongoing pharmaceutical promotion for 49 major pharmaceutical companies including Astellas, AstraZeneca, Takeda, Daiichi Sankyo, Chugai, GSK, and Novartis

Named customers42 records

Segments3 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature2 records

Partnerships

Eight partnerships are on record, tiered core and minor.

• 株式会社VivixycoreStrategic or Co-development Partner · 26 January 2026Parent company MIHD acquired 51% of Vivixy's issued shares to make it a subsidiary. Vivixy is a technology company with engineers skilled in AI and web technologies, providing strong AI development capability to the group. The acquisition aims to fuse MIHD's business foundation with Vivixy's AI development power for new AI-based business creation and group-wide AI adoption, including joint development of AI solutions for healthcare professionals.
• 株式会社 медицинノート (Medical Note Co., Ltd.)coreStrategic or Co-development Partner · 12 November 2024Medical Review's parent company MIHD strengthened collaboration with Medical Note in disease awareness marketing. Medical Note operates Japan's large patient-facing medical information platform 'Medical Note' and has worked with 1,064 medical institutions and 33 pharmaceutical/medical device companies on disease awareness. The partnership enables comprehensive marketing support covering both physician and patient audiences through patient journey-based approaches.
• медицинский Интеллидженс Холдингс株式会社 (Medical Intelligence Holdings Co., Ltd.)coreStrategic or Co-development Partner · 1 August 2024Parent company of Medical Review Co., Ltd. Formerly known as 恒星出版株式会社 (Kosei Shuppan), renamed to Medical Intelligence Holdings Co., Ltd. in August 2024. Operates group companies including Medical Review, Interscience, Medical Professional Relations, and Hearts, with approximately 330 group-wide employees.
• 株式会社 интернациональная наука (Interscience Co., Ltd.)coreOthersRelated company within the MIHD group. Operates as a pharmaceutical advertising agency with Japan's largest number of medical writers.
• 関西テレビ放送株式会社 / 株式会社フジテレビジョンminorGTM or Marketing PartnerJoint organizers of ORGAN ROOMS カラダワンダーランド public health education events for families in Osaka (Kansai TV) and Tokyo (Fuji TV). Events included government backing from Ministry of Health, Labour and Welfare and Japan Medical Association.
• 株式会社桜十字ホールディングス / JCRファーマ株式会社minorGTM or Marketing PartnerSponsors of ORGAN ROOMS カラダワンダーランド events, supporting public health education initiatives organized by Medical Review.
• 国立成育医療研究センターminorOthersNational Center for Child Health and Development — its chairman (五十嵐 隆) served as instructor at ORGAN ROOMS health education events.
• 在京 小田 母子医療センター / 大阪母子医療センターminorOthersMedical expert (和田 和子, Deputy Director) from Osaka Medical Center for Mother and Child Health participated as instructor at ORGAN ROOMS events.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Publicis Health: Global healthcare communications network within Publicis Groupe providing pharma advertising, medical communications, and health technology solutions. Competes for the same multinational pharma marketing budgets as Medical Review.
• Hakuhodo: Japan's second-largest advertising agency with a dedicated healthcare communications division serving pharma clients. Overlaps with Medical Review's HCP promotion and medical strategy work but operates at much greater scale across multiple industries.
• ADK Holdings: Major Japanese advertising group with established healthcare/pharma practice serving enterprise clients across categories. Comparable to Medical Review in pharma advertising capability but with broader portfolio beyond healthcare.
• Ogilvy Health: WPP-owned global healthcare communications agency offering brand promotion, medical education, and patient engagement services. Directly competes for major pharma promotional accounts with a global delivery footprint.
• Dentsu Inc. Largest Japanese advertising agency group with a substantial healthcare and pharmaceutical communications practice. Competes for the same major pharma promotional budgets as Medical Review, with far broader geographic and category reach.
• McCann Health (IPG Health): Global healthcare communications network within IPG serving major pharma with creative, medical communications, and patient engagement. Comparable in pharmaceutical promotional work but operates at global scale with deep multinational pharma client relationships.

Emerging players

• Medical Note Co., Ltd. Patient-facing medical information platform partnered with Medical Review's parent MIHD, having worked with 1,064 medical institutions and 33 pharma/medical device companies. Comparable as a healthcare content platform, though focused on the patient/consumer side rather than HCP promotion.

Others

• IQVIA Japan: Global health data and clinical research services firm with Japan operations providing pharma commercial analytics and consulting. Adjacent to Medical Review's pharma communications business through shared pharma client base and commercial-focused services.
• CMIC Group: Japanese pharmaceutical services group including CRO, CDMO, and pharma sales support businesses. Adjacent to Medical Review's pharma promotional work as part of the broader pharma services ecosystem in Japan.

Direct peers

• Interscience Co., Ltd. Sister company within the MIHD holding group and Japan's pharmaceutical advertising agency with the largest number of medical writers. Directly comparable in offering medical copywriting, pharma promotion, and HCP-targeted communications to Japanese pharma manufacturers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/%E6%A0%AA%E5%BC%8F%E4%BC%9A%E7%A4%BE%E3%83%A1%E3%83%87%E3%82%A3%E3%82%AB%E3%83%AB%E3%83%AC%E3%83%93%E3%83%A5%E3%83%BC%E7%A4%BE

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about 株式会社メディカルレビュー社